Anti-TL1A Neutralizing Antibody

Only %1 left
Catalog #
101729
As low as $395 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

This anti-TL1A (TNF-like ligand 1A) antibody is a purified, recombinant human monoclonal antibody which recognizes the human TL1A protein. TL1A is also known as vascular endothelial growth inhibitor, VEGI and TNFSF15 (Tumor Necrosis Factor Super Family 15).

Synonyms
TNFSF15, TL1, VEGI, TNF ligand-related molecule 1, Vascular endothelial cell growth inhibitor
Product Info
Storage and Usage
Citations
Species
Human
Isotype
lgG1
Clonality
Monoclonal
Host Species/Expression System
HEK293
Purity

≥90%

Purification
Protein A affinity chromatography from HEK293 supernatants.
Format

Aqueous buffer solution.

Formulation

8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

MW
Heavy Chain: 49 kDa + glycans; Light Chain: 23 kDa
Glycosylation
This antibody runs at a higher MW by SDS-PAGE due to glycosylation.
UniProt #
O95150
Background

TL1A is involved in immune regulation by binding to two receptors of the TNF (Tumor Necrosis Factor) family present in T and NK cells: DR3 and DcR3. Soluble TL1A induces CD4+ T cell proliferation and cytokine secretion.  TL1A bound to DR3 can switch immune response towards type 1 T-helper cells. Dysregulation can lead to pathologies such as inflammatory bowel disease (IBD) and other auto-immune diseases. TL1A is thus an attractive target for auto-immune disease treatment.